JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, B. E.
Right arrow Articles by Maina, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, B. E.
Right arrow Articles by Maina, T.
Journal of Nuclear Medicine Vol. 46 No. 11 1889-1897
© 2005 by Society of Nuclear Medicine


Basic Science Investigations

MicroPET Imaging of Gene Transfer with a Somatostatin Receptor–Based Reporter Gene and 94mTc-Demotate 1

Buck E. Rogers, PhD1, Jesse J. Parry, BS1, Rebecca Andrews1, Paul Cordopatis, PhD2, Berthold A. Nock, PhD3 and Theodosia Maina, PhD3

1 Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
2 Department of Chemistry, University of Patras, Patras, Greece
3 Institute of Radioisotopes–Radiodiagnostic Products, National Center for Scientific Research Demokritos, Athens, Greece

Gene therapy trials would benefit greatly from the use of noninvasive imaging to determine the location, magnitude, and time course of gene transfer. Somatostatin receptor subtype 2 (SSTR2) has been used as a reporter probe for {gamma}-camera imaging of gene transfer in animal models. PET has greater sensitivity than {gamma}-camera imaging and therefore would have an advantage for the imaging of SSTR2 gene transfer. Methods: An adenovirus (AdHASSTR2) carrying sstr2, which encodes an N-terminal hemagglutinin epitope, was used for evaluating SSTR2 gene transfer. The somatostatin analog Demotate 1 (Tyr3-octreotate conjugated to the 1,4,8,11-tetraazaundecane chelator) was used for chelation of the positron emitter 94mTc (half-life, 52 min) and targeting to SSTR2. Gene transfer was evaluated in vitro with A-427 non–small cell lung cancer cells after infection with AdHASSTR2 by 94mTc-Demotate 1 binding and internalization assays. In vivo biodistribution and microPET studies were conducted with mice bearing A-427 tumor xenografts directly injected with AdHASSTR2 to determine the tumor localization of 94mTc-Demotate 1. Results: 94mTc-Demotate 1 bound with high affinity and was internalized rapidly into AdHASSTR2-infected A-427 cells. Biodistribution studies showed uptake of 94mTc-Demotate 1 in tumors infected with AdHASSTR2 (4.0 percentage injected dose per gram [%ID/g] at 2 h) and background uptake in tumors infected with a control adenovirus (0.8 %ID/g at 2 h). The uptake of 94mTc-Demotate 1 in AdHASSTR2-infected tumors was greater than the uptake in all other tissues, except for the kidneys and the SSTR2-positive pancreas. MicroPET imaging showed similar results, with clear uptake of 94mTc-Demotate 1 in AdHASSTR2-infected tumors, background uptake in control tumors, and clearance through the kidneys. Conclusion: These studies show that the positron-emitting somatostatin analog 94mTc-Demotate 1 could be used to determine SSTR2 gene transfer by microPET imaging, a result that will improve the sensitivity of the SSTR2 reporter gene system.

Key Words: somatostatin receptor • gene transfer • PET • 94mTc • adenovirus


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 7a-8a. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.